Publications (29) DAVINIA LARROSA CAMPO publications

2024

  1. Patología neurovascular en el paciente con neurofibromatosis de tipo 1. A propósito de un caso

    Revista de neurologia, Vol. 79, Núm. 4, pp. 115-118

2022

  1. Serum Prealbumin Levels on Admission as a Prognostic Marker in Stroke Patients Treated with Mechanical Thrombectomy

    Cerebrovascular Diseases Extra, Vol. 12, Núm. 3, pp. 103-108

2020

  1. Dual energy CT in the management of antiplatelet therapy in patients with acute ischemic stroke for carotid obstruction

    Interventional Neuroradiology, Vol. 26, Núm. 2, pp. 222-230

  2. No association between migraine frequency, white matter lesions and silent brain infarctions: a study in a series of women with chronic migraine

    European Journal of Neurology, Vol. 27, Núm. 8, pp. 1689-1696

2019

  1. Global Orbital Infarction Syndrome after a Carotid Artery Dissection

    JAMA Neurology

  2. Orthostatic tremor as the only manifestation of thyrotoxicosis following cerebral angiography

    Neurologia

2018

  1. Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study

    Revista Clinica Espanola, Vol. 218, Núm. 7, pp. 327-335

2017

  1. Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain

    Revista de Neurologia, Vol. 65, Núm. 8, pp. 361-367

2016

  1. Analysis of endovascular treatment of ruptured microaneurysms compared with ruptured larger aneurysms

    Journal of NeuroInterventional Surgery, Vol. 8, Núm. 6, pp. 586-590

  2. Convexity subarachnoid haemorrhage secondary to internal carotid stenosis: An indication for revascularisation

    BMJ Case Reports, Vol. 2016

  3. Dilemma in the emergency setting: Hypomagnesemia mimicking acute stroke

    International Medical Case Reports Journal, Vol. 9, pp. 145-148

  4. El código ictus de Asturias

    Neurologia, Vol. 31, Núm. 3, pp. 143-148

  5. No Relationship Between Patent Foramen Ovale and Migraine Frequency

    Headache, Vol. 56, Núm. 9, pp. 1466-1473

  6. Safety and Efficacy of Mechanical Thrombectomy in Acute Ischemic Stroke of Anticoagulated Patients—A Prospective Observational Study

    Journal of Stroke and Cerebrovascular Diseases, Vol. 25, Núm. 9, pp. 2093-2098

  7. Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack

    Revista de Neurologia, Vol. 62, Núm. 5, pp. 203-210

2015

  1. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine

    Cephalalgia, Vol. 35, Núm. 4, pp. 310-316

  2. Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?

    Cephalalgia, Vol. 35, Núm. 10, pp. 864-868

  3. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine

    Pain, Vol. 156, Núm. 5, pp. 820-824

2014

  1. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine

    Headache, Vol. 54, Núm. 6, pp. 987-995

  2. Chronic migraine does not increase posterior circulation territory (PCT) infarct-like lesions

    Journal of the Neurological Sciences, Vol. 336, Núm. 1-2, pp. 180-183